BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Genetown

  SmartPharm Therapeutics Announces Presentation at the 2019 BIO Investor Forum

  SmartPharm Therapeutics announced that José Trevejo, MD, PhD, Chief Executive Officer, will present at the 2019 BIO Investor Forum on Wednesday, October 23 at 9:00 a.m. PT in San Francisco..

  October 16, 2019

   · 

  1 min read
• Pharm Country

  OTC Markets Group Welcomes Ceapro Inc. to OTCQX

  OTC Markets Group Inc. announced Ceapro Inc., a growth-stage biotechnology company focused on the development and commercialization of active ingredients for the healthcare and cosmetic industries, has qualified to trade on the OTCQX® Best Market..

  October 16, 2019

   · 

  3 min read
• BioCapital

  Incyte Announces that the REACH2 Pivotal Trial of Ruxolitinib (Jakafi®) Meets Primary Endpoint in Patients with Steroid-Refractory Acute Graft-Versus-Host Disease

  Results of randomized Phase 3 REACH2 trial show that ruxolitinib significantly improves overall response rate (ORR) at 28 days vs. best available therapy in patients with steroid-refractory acute graft-versus-host disease (GvHD)

  October 16, 2019

   · 

  8 min read
• Business

  Orchestra BioMed™ Strengthens Management Team with Appointments of Expert Product Development Leaders Juan A. Lorenzo and Paul V. Goode, Ph.D.

  Orchestra BioMed, Inc. (“Orchestra BioMed” or the “Company”), a biomedical innovation company providing high-impact solutions for large unmet needs in procedure-based medicine, today announced senior-level appointments to its product development teams.

  October 16, 2019

   · 

  6 min read
• Pharm Country

  Sun Pharma Launches Drizalma Sprinkle in the U.S.

  Sun Pharmaceutical Industries Ltd. announced that one of its wholly owned subsidiaries has launched Drizalma Sprinkle™ in the U.S. for oral use.

  October 16, 2019

   · 

  8 min read
• Adaptate Biotherapeutics formed to develop antibody-based therapies that modulate gamma delta T-cells

  GammaDelta Therapeutics spins-out new company to accelerate antibody-based assets towards clinical studies

  October 16, 2019

   · 

  3 min read
• Business

  Aroa Biosurgery Appoints New Vice President, Commercial

  Aroa Biosurgery, a New Zealand-headquartered, emerging global leader for tissue regeneration products used in complex wounds and soft tissue repair, has announced the appointment of a highly experienced U.S. based executive, Brad Adams, to the new position of Vice President, Commercial..

  October 16, 2019

   · 

  2 min read
• Pharm Country

  Celgene and the Multiple Sclerosis Association of America Take the MS MindShift Initiative and “Brain Bulb” Hot Air Balloon to the Sky at Owl-O-Ween Festival to Educate on Multiple Sclerosis and Brain Health

  The MS MindShift: A New View of MS initiative from Celgene Corporation and the Multiple Sclerosis Association of America is making its third stop at the Owl-O-Ween Hot Air Balloon Festival in Kennesaw, Ga., on October 18 and 19.

  October 16, 2019

   · 

  5 min read
• Business

  Insilico Medicine and ChemDiv form a strategic drug discovery service alliance

  Insilico Medicine and ChemDiv, Inc. launched a new strategic collaboration to provide certain pharmaceutical and biotechnology companies with end-to-end drug discovery solutions.

  October 16, 2019

   · 

  2 min read
• Deals

  DaVita’s Corporate Responsibility Efforts Earn Accolades from Dow Jones

  Company makes Dow Jones Sustainability Indices for the third time

  October 16, 2019

   · 

  3 min read